Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABBV | JNJ | NVS | ||
| Company | Abbvie Inc | Johnson & Johnson | Novartis Ag ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 229.46 | 206.00 | 139.06 | ||
| High | 230.80 | 207.94 | 139.48 | ||
| Low | 228.98 | 205.57 | 138.53 | ||
| Latest | 229.89 | 207.78 | 138.88 | ||
| Change | +1.10 | +2.00 | -0.25 | ||
| % Change | +0.48% | +0.97% | -0.18% | ||
| Volume | 1,744,900 | 2,376,500 | 646,900 | ||
| 20-Day Average Volume | 5,482,830 | 8,702,430 | 1,667,985 | ||
| Previous Close | 228.79 | 205.78 | 139.13 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 226.01 | 206.70 | 133.46 | ||
| 20-Day Raw Stochastic | 78.86% | 51.54% | 88.50% | ||
| 20-Day Relative Strength | 54.27 | 59.09 | 66.45 | ||
| Weighted Alpha | +29.72 | +46.43 | +41.15 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 80% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.49% since 12/17/25 | -1.21% since 12/17/25 | +2.85% since 12/17/25 | ||
| Low | 222.35 on 12/19/25 | 203.28 on 12/23/25 | 134.82 on 12/19/25 | ||
| High | 230.80 on 12/24/25 | 211.06 on 12/18/25 | 140.18 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | +0.17% since 11/24/25 | +0.84% since 11/24/25 | +9.75% since 11/24/25 | ||
| Low | 220.23 on 12/09/25 | 199.90 on 12/09/25 | 128.75 on 11/25/25 | ||
| High | 234.08 on 11/25/25 | 215.18 on 12/15/25 | 140.18 on 12/23/25 | ||
| 3-Month | |||||
| %Chg | +4.50% since 09/24/25 | +17.60% since 09/24/25 | +12.91% since 09/24/25 | ||
| Low | 211.69 on 11/03/25 | 175.91 on 09/25/25 | 121.57 on 10/29/25 | ||
| High | 244.81 on 10/01/25 | 215.18 on 12/15/25 | 140.18 on 12/23/25 | ||
| 6-Month | |||||
| %Chg | +23.90% since 06/24/25 | +36.53% since 06/24/25 | +16.87% since 06/24/25 | ||
| Low | 181.73 on 06/27/25 | 150.73 on 06/25/25 | 112.34 on 08/01/25 | ||
| High | 244.81 on 10/01/25 | 215.18 on 12/15/25 | 140.18 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 406,304,128 | 500,603,264 | 293,373,184 | ||
| Shares Outstanding, K | 1,767,385 | 2,409,295 | 2,112,422 | ||
| Annual Sales | 56,334,000,000 | 88,821,000,000 | 51,722,000,000 | ||
| Annual Net Income | 4,278,000,000 | 14,066,000,000 | 11,941,000,000 | ||
| Last Quarter Sales | 15,776,000,000 | 23,993,000,000 | 14,358,000,000 | ||
| Last Quarter Net Income | 186,000,000 | 5,152,000,000 | 3,928,000,000 | ||
| 60-Month Beta | 0.36 | 0.36 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.86 on 10/31/25 | 2.80 on 10/14/25 | 2.25 on 10/28/25 | ||
| Latest Earnings Date | 01/30/26 | 01/21/26 | 01/30/26 | ||
| Most Recent Dividend | 1.640 on 10/15/25 | 1.300 on 11/25/25 | 2.596 on 03/12/25 | ||
| Next Ex-Dividends Date | 01/16/26 | 11/25/25 | 03/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 24.21 | 19.82 | 15.58 | ||